B

Bio-Gene Technology Ltd
ASX:BGT

Watchlist Manager
Bio-Gene Technology Ltd
ASX:BGT
Watchlist
Price: 0.023 AUD Market Closed
Market Cap: 7m AUD

Bio-Gene Technology Ltd
Investor Relations

Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticide products. The company is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Timothy Owen Grogan B.Sc., LLB
MD, CEO & Director
No Bio Available
Mr. Edmond Tern B.A., CPA
CFO & Company Secretary
No Bio Available
Mr. Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBA
Executive Director of Research & Development and Executive Director
No Bio Available

Contacts

Address
VICTORIA
Melbourne
Melbourne, Victoria, L 11 456 Lonsdale Street
Contacts
+61396284178.0
bio-gene.com.au